Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.1 HKD | +1.38% | -4.12% | +5.74% |
May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
May. 14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.74% | 893M | |
-2.29% | 89.38B | |
-3.68% | 37.92B | |
-14.91% | 32.04B | |
+61.53% | 26.03B | |
-22.72% | 14.14B | |
-8.73% | 12.88B | |
-10.57% | 11.77B | |
+3.75% | 8.92B | |
-18.13% | 7.34B |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Transcript : Calliditas Therapeutics AB, Everest Medicines Limited - Special Call